The Endpoints Slack interview: Lux's Josh Wolfe on AI hype, biotech markets, Twitter and more
We’re trying something new! Welcome to the first Endpoints Slack Interview, where we chat with interesting people in biotech, pharma, venture capital and science about what they’re working on, what they think and who they are.
Our first conversation is with Josh Wolfe, cofounder and managing partner of Lux Capital. He logged in to our top secret Slack channel last week, and the conversation has been very minimally edited for readability.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.